What is Lifecore Biomedical, Inc.'s work in process?

Lifecore Biomedical, Inc. (LFCR) reported work in process of $13.47M in Q1 2026.

What is the long-term trend for Lifecore Biomedical, Inc.'s work in process?

Over 2 years (2023 to 2026), Lifecore Biomedical, Inc.'s work in process has grown at a 14.1% compound annual growth rate (CAGR), from $10.35M to $13.47M.

What does work in process mean?

Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.

Lifecore Biomedical, Inc. LFCR Work in process

Work in process at other companies

ADMA BiologicsADMA

$67.53M+35.7%

BioCryst PharmaceuticalsBCRX

$20.54M+17.9%

Baxter InternationalBAX

——

Thermo Fisher ScientificTMO

——

Charles River LaboratoriesCRL

——

West Pharmaceutical ServicesWST

——

Other financials

Income statement

See full

Revenue$23.2M-36.4%

Gross profit$4.5M-68.1%

Operating income-$4.7M—

Net income-$15.0M-1,206%

EPS (diluted)-$0.43-1,333%

Balance sheet

See full

Cash & equivalents$20.8M+152%

Total debt$156.9M+1,310%

Total equity-$28.4M-2,229%

Total assets$225.5M-5.8%

Cash flow

See full

Operating cash flow$4.7M—

CapEx$1.1M-46.7%

Free cash flow$3.6M—

Valuation

See full

Market cap$196.92M-35.4%

Enterprise value$333.06M+8.3%

P/S1.6×+0.5×

Profitability

See full

Gross margin31.3%-1.4pp

Operating margin-14.5%-2.2pp

Net margin-30%—

FCF margin-36.4%—

Returns & leverage

See full

Return on equity-612.1%—

Debt / equity8.3×-1.5×

Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InventoryWorkInProcess.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s work in process.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s work in process?: Lifecore Biomedical, Inc. (LFCR) reported work in process of $13.47M in Q1 2026.
What is the long-term trend for Lifecore Biomedical, Inc.'s work in process?: Over 2 years (2023 to 2026), Lifecore Biomedical, Inc.'s work in process has grown at a 14.1% compound annual growth rate (CAGR), from $10.35M to $13.47M.
What does work in process mean?: Partially completed goods currently in the manufacturing process, including materials, labor, and overhead costs incurred to date.